Medpace Holdings, Inc.

US$653.11As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MEDPHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 36.44%
Div yield —
ROE 117.88%
Diagnostics & Research
Beta (5Y) 1.11
PE TTM 36.22
TSR TTM 11.66%
Mkt cap US$18.27B
ROIC 793.61%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$628
(3.77%)
80.49%
Hold 11|5|1|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
7.36
7.35
7.82
8.01
25.02%
17.52%
19.81%
12.05%
Revenue$B
1.543
1.603
1.695
1.669
11.22%
12.88%
14.33%
12.75%
Peers (US$18.27B)
Cap (US$)
PE
17.31B
68.65x
17.00B
34.65x
Capital
TTM
5Y
10Y
Leveragex
0.196
(0.188)
(0.129)
EBIT/Intx
8.349
0.253
0.252
Own earn%
36.61
(139.89)
(90.31)
Sh yield%
44.03
47.48
46.42
Owners
Insiders/Inst%
2.16
85.46
Short interest%
1.35
SBC / revenue%
1.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
20–32
$1 testx
—
Incr. ROIC%
0